{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:18:50Z","timestamp":1760980730442},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,4,1]],"date-time":"1986-04-01T00:00:00Z","timestamp":512697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J, Clin. Microbiol."],"published-print":{"date-parts":[[1986,4]]},"DOI":"10.1007\/bf02013994","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T16:02:19Z","timestamp":1123776139000},"page":"220-225","source":"Crossref","is-referenced-by-count":42,"title":["Clinical experience with ciprofloxacin in the USA"],"prefix":"10.1007","volume":"5","author":[{"given":"G.","family":"Arcieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"August","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gruenwaldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02013994_CR1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.24.4.568","volume":"24","author":"R. Fass","year":"1983","unstructured":"Fass, R.: In vitro activity of ciprofloxacin (Bay 0 9867). Antimicrobial Agents and Chemotherapy 1983, 24: 568\u2013574.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013994_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02001575","volume":"2","author":"A. Bauernfeind","year":"1983","unstructured":"Bauernfeind, A., Petermueller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111\u2013115.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013994_CR3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/clpt.1984.192","volume":"36","author":"G. Aronoff","year":"1984","unstructured":"Aronoff, G., Kenner, C., Sloan, R., Pottratz, S.: Multiple-dose ciprofloxacin kinetics in normal subjects. Clinical Pharmacology and Therapeutics 1984, 36: 384\u2013388.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF02013994_CR4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.26.2.208","volume":"26","author":"R. Wise","year":"1984","unstructured":"Wise, R., Lockley, R., Webberly, M., Dent, J.:Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrobial Agents and Chemotherapy 1984, 26: 208\u2013210.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013994_CR5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/AAC.28.2.308","volume":"28","author":"L. Eron","year":"1985","unstructured":"Eron, L., Harvey, L., Hixon, D., Poretz, D.: Ciprofloxacin therapy of infections caused byPseudomonas aeruginosa and other resistant bacteria. Antimicrobial Agents and Chemotherapy 1985, 28: 308\u2013310.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013994_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.28.1.128","volume":"28","author":"C. Ramirez","year":"1985","unstructured":"Ramirez, C., Bran, J., Mejia, C., Garcia, J.: Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1985, 28: 128\u2013132.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013994_CR7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02013997","volume":"5","author":"F. Follath","year":"1986","unstructured":"Follath, F., Bindschedler, M., Wenk, M., Frei, R., Stalder, H., Rebel, H.:Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. European Journal of Clinical Microbiology 1986, 5: 236\u2013240.","journal-title":"European Journal of Clinical Microbiology"}],"container-title":["European Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02013994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02013994\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02013994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T18:25:33Z","timestamp":1557771933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02013994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,4]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,4]]}},"alternative-id":["BF02013994"],"URL":"https:\/\/doi.org\/10.1007\/bf02013994","relation":{},"ISSN":["0722-2211","1435-4373"],"issn-type":[{"value":"0722-2211","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,4]]}}}